Sareum Holdings (GB:SAR) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Sareum Holdings PLC, a biotech firm focused on developing kinase inhibitors for autoimmune diseases and cancer, has announced its Annual General Meeting to be held on December 19, 2024, in London. The company, which trades under the ticker SAR on the AIM market, will also provide online access to the AGM for shareholders via the Investor Meet Company platform. Sareum’s leading candidate, SDC-1801, has completed Phase 1 clinical development, showcasing potential in treating autoimmune diseases.
For further insights into GB:SAR stock, check out TipRanks’ Stock Analysis page.